Tag : medical trials

Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, today announced it is acquiring PatientSafe Solutions based in San Diego, CA. PatientSafe...

Phase 1a/1b clinical trials beginning April 2021 will assess the safety and tolerability of ZYUS’ lead drug product candidate in healthy adult participants ZYUS Life...

Deep Lens and Oregon Oncology Specialists today announced a strategic collaboration that will integrate Deep Lens’ artificial-intelligence (AI)-based clinical trial screening platform, VIPER™, into their...

My Intelligent Machines Inc. (“MIMs”), a leader in artificial intelligence and systems biology, today announced that it has completed an equity financing of $5 million....

First-of-its Kind Integrated Platform to Further Support Members with Chronic Conditions Today Omada Health announced the launch of Physician-Guided Care for diabetes and hypertension, creating the first...

The Omada Insights Lab leverages over a billion data points across more than 450,000 members’ interactions to individualize and optimize care delivery, improve health outcomes,...

Prescryptive Health, a health intelligence platform focused on improving the prescription drug market and the pharmacy experience, teams with Pear to make innovative prescription digital...

Pre-configured solution reduces study start up time and costs of collecting outcomes data Signant Health, a leading enabler of evidence generation for modern clinical trials,...

Funding enables company to advance first-in-human studies for its flagship product, a less-invasive neuromodulation device for treating neurological conditions using artificial intelligence and graphene electrodes...